Roger K. Cady
Corporate Officer/Principal at ALDER BIOPHARMACEUTICALS, INC.
Roger K. Cady active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ALDER BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | 2016-06-05 | - |
| National Headache Foundation | Director/Board Member | - | - |
Career history of Roger K. Cady
Former positions of Roger K. Cady
| Companies | Position | Start | End |
|---|---|---|---|
Shealy Institute for Comprehensive Pain
 Shealy Institute for Comprehensive Pain Medical/Nursing ServicesHealth Services Part of Cluster Technology Corp., Shealy Institute for Comprehensive Pain is a medical clinic for pain management. The company is based in Springfield, MO. Shealy Institute for Comprehensive Pain was acquired by Cluster Technology Corp. on January 21, 1998. | Chief Tech/Sci/R&D Officer | - | - |
Primary Care Network, Inc.
 Primary Care Network, Inc. Medical/Nursing ServicesHealth Services Primary Care Network, Inc. provides health care services. The company is headquartered in Springfield, MO. | Founder | - | - |
Training of Roger K. Cady
| Drake University | Undergraduate Degree |
| Mayo Medical School | Doctorate Degree |
Statistics
International
| United States | 6 |
| 2 |
Operational
| Corporate Officer/Principal | 1 |
| Founder | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Health Services | 3 |
| Consumer Services | 3 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 4 |
|---|---|
Shealy Institute for Comprehensive Pain
Shealy Institute for Comprehensive Pain Medical/Nursing ServicesHealth Services Part of Cluster Technology Corp., Shealy Institute for Comprehensive Pain is a medical clinic for pain management. The company is based in Springfield, MO. Shealy Institute for Comprehensive Pain was acquired by Cluster Technology Corp. on January 21, 1998. | Health Services |
Primary Care Network, Inc.
Primary Care Network, Inc. Medical/Nursing ServicesHealth Services Primary Care Network, Inc. provides health care services. The company is headquartered in Springfield, MO. | Health Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |
| National Headache Foundation |
- Stock Market
- Insiders
- Roger K. Cady
- Experience
